Taxotere Epiphora Lawsuit Filed Over Excessively Watery Eyes
Lawsuit alleges Taxotere caused epiphora in both eyes, joining a growing number of claims being pursued by former users of the chemotherapy drug left with debilitating watery eyes
Lawsuit alleges Taxotere caused epiphora in both eyes, joining a growing number of claims being pursued by former users of the chemotherapy drug left with debilitating watery eyes
Side effects of Taxotere may cause sudden eye problems or result in permanent hair loss. Lawsuits reviewed nationwide.
Sanofi claims the lawsuits are preempted because Taxotere warning label included information about blocked tear ducts since 2002, despite plaintiffs' arguments the warnings are too vague
Sanofi claims the Taxotere lawsuits over excessive tearing should be dismissed because of a warning added to the label in 2002.
Woman indicates that she was left with a tear duct obstruction from Taxotere, a breast cancer drug, which resulted in debilitating watery eyes
The side effects of Taxotere and similar chemotherapy drugs increased the risk of epiphora by a factor of seven, according to the findings
New trial ordered in the first Taxotere bellwether claim that resulted in a defense verdict in 2019, finding that inappropriate expert testimony was introduced by a Sanofi.
MDL Judges said there appear to be at least 100 Taxotere eye injury cases waiting to be filed by plaintiffs who experienced vision problems due excessive tearing and watery eyes caused by Taxotere.
Lawsuits over Taxotere eye injuries have been filed in multiple U.S. District Courts, raising the risk of duplicative discovery into common issues and conflicting pretrial rulings from different judges
Lawsuit alleges Docetaxel Injections for breast cancer chemotherapy caused permanent excessive tearing of the eyes